Michael Winder

ORCID: 0000-0003-2527-4713
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urinary Bladder and Prostate Research
  • Neuroscience of respiration and sleep
  • Nitric Oxide and Endothelin Effects
  • Pelvic floor disorders treatments
  • Sexual function and dysfunction studies
  • Neuropeptides and Animal Physiology
  • Adenosine and Purinergic Signaling
  • Urological Disorders and Treatments
  • Circadian rhythm and melatonin
  • Receptor Mechanisms and Signaling
  • Hormonal and reproductive studies
  • Urinary Tract Infections Management
  • Parkinson's Disease Mechanisms and Treatments
  • Ocular Surface and Contact Lens
  • Salivary Gland Disorders and Functions
  • Vagus Nerve Stimulation Research
  • Nicotinic Acetylcholine Receptors Study
  • Advanced Glycation End Products research
  • Caveolin-1 and cellular processes
  • Eicosanoids and Hypertension Pharmacology
  • Ion Channels and Receptors
  • Medical Education and Admissions
  • Cancer, Stress, Anesthesia, and Immune Response
  • Renal Diseases and Glomerulopathies
  • Ion channel regulation and function

University of Gothenburg
2016-2025

Abstract Background The aim of the present study was to investigate effects chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on bladder function and pathophysiology. Methods To create a model for CPPS, rats were intraprostatically injected with zymosan or saline, serving as control. Metabolic cage experiments performed 7, 14, 21 days after injection 14 in control group. Thereafter, cystometry which simulated micturition cycles induced by saline infusion contractile responses...

10.1002/pros.24101 article EN cc-by-nc-nd The Prostate 2021-01-19

Cyclophosphamide-induced cystitis alterations have been reported to occur both at efferent and afferent level in the micturition reflex arc. In particular, stretching of bladder wall causing urothelial release ATP has proposed as one pivotal mechanisms these alterations. To evaluate functional changes levels following cyclophosphamide treatment we applied a novel situ half rat model.Male Sprague-Dawley rats were treated with either saline or (100 mg/kg), stretch-, electric-, methacholine-,...

10.1002/nau.22562 article EN Neurourology and Urodynamics 2014-01-31

Nitric oxide (NO) has pivotal roles in cyclophosphamide- (CYP-) induced cystitis during which mucosal nitric synthase (NOS) and muscarinic M5 receptor expressions are upregulated. In cystitis, urothelial NO-linked effects hamper contractility. Therefore we wondered if a blockade of this axis also affects the induction rat. Rats were pretreated with saline, antagonist 4-DAMP (1 mg/kg ip), or NOS inhibitor L-NAME (30 ip) for five days. 60 h before experiments rats treated saline CYP....

10.1155/2014/359179 article EN cc-by BioMed Research International 2014-01-01

Abstract Today, monotherapy is the most common pharmacological treatment option for patients suffering from overactive bladder (OAB). Recent reports have indicated potential benefits of combination therapy, using a muscarinic antagonist and β 3 ‐adrenoceptor agonist. This may be particular interest therapy‐resistant with OAB concomitant cystitis. The objective current study was to assess how therapy affects parameters in health cystitis if efficacy drugs can linked altered release nitric...

10.1002/prp2.564 article EN cc-by Pharmacology Research & Perspectives 2020-02-01

The search for new animal models to investigate both efferent and afferent levels of the micturition reflex, better understand urinary dysfunctions, is great importance. Therefore in this study we developed characterized, by comparisons with a conventional whole bladder model, novel situ model.The was carefully prepared separated, via midline incision, into two halves all way urethra pentobarbitone medetomidine anesthetized male rats. separated (with no direct connection) were immobilized...

10.1002/nau.22435 article EN Neurourology and Urodynamics 2013-05-29

Chronic pelvic pain syndrome (CPPS) is a common and bothersome condition for which no pharmacological treatment options with acceptable efficacy exist. The aim of this study was to investigate the effects soluble guanylate cyclase (sGC) activator BAY 60-2770 COX-2 inhibitor celecoxib on bladder function in rat model CPPS.Forty-eight male Sprague-Dawley rats were intraprostatically injected either saline, serving as control, or zymosan, induce prostatitis. On days 8-20, treated...

10.1016/j.ejphar.2022.175052 article EN cc-by European Journal of Pharmacology 2022-05-26

Urinary problems, including urinary frequency, urgency, and nocturia are some of the non-motor symptoms that correlate most with poor quality life in Parkinson's disease. However, mechanism behind these is poorly understood, particular regarding peripheral bladder pathophysiology following dopamine degeneration.

10.3233/jpd-140509 article EN other-oa Journal of Parkinson s Disease 2015-06-01

Mechanical stretch of the urothelium induces release ATP that activates bladder afferent nerves. In rat urinary bladder, is also a contractile co-transmitter in parasympathetic innervation. isolated preparations, evokes urothelial acetylcholine substantially contributes to ATP-evoked responses. Currently we aimed further examine interactions and two vivo models. whole preparation, atropine reduced responses by about 50% intact but denervated bladders, while had no effect after denudation...

10.1016/j.autneu.2020.102689 article EN cc-by Autonomic Neuroscience 2020-05-23

In the urinary bladder, main source of NO seems to be urothelium and underlying suburothelium. this study, we aimed characterize how receptors in human regulate production release NO. For this, cultured two urothelial cell lines - normal immortalized line UROtsa malignant T24. These were treated with an array agonists antagonists affinity for adrenergic, muscarinic purinergic receptors. The expression nitric oxide synthase (NOS) was studied by immunocytochemistry Western blotting. amount...

10.1111/bcpt.12799 article EN Basic & Clinical Pharmacology & Toxicology 2017-04-24

Abstract Adequate knowledge in pharmacology is crucial many professions but a non-negligible proportion of students fail the exams and underlying factors largely lacking. This study was performed to evaluate what extent various are related student performance pharmacology-related courses higher education, linking administrative data attendance at non-mandatory teaching sessions questionnaire replies. A total 596 (median age: 22 years; 70% female) were included from eight which part either...

10.1007/s40670-020-01026-8 article EN cc-by Medical Science Educator 2020-07-13

Gastrointestinal dysfunction is one of the most common non-motor symptoms in Parkinson's disease (PD). The exact mechanisms behind these are not clearly understood. Studies well-established 6-hydroxydopamine (6-OHDA) lesioned rats PD have shown altered contractility isolated circular and longitudinal smooth muscle strips distal colon. Contractile changes proximal colon ileum nevertheless poorly studied. Moreover, segments may serve as better tissue preparations to understand interplay...

10.1155/2023/9090524 article EN cc-by Gastroenterology Research and Practice 2023-01-27

Abstract Background The aim of the current study was to investigate effects chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on bladder function via prostate-to-bladder cross-sensitization in a rat model lipopolysaccharide (LPS)-induced prostate inflammation. Methods Male rats were intraprostatically injected with LPS or saline, serving as control. Micturition parameters examined metabolic cage 10 14 days later. Subsequently, evaluate function, cystometry performed. cycles induced...

10.1186/s12894-021-00882-9 article EN cc-by BMC Urology 2021-08-21

Summary Obidoxime, a weak acetylcholine‐esterase ( AC hE) inhibitor, exerts muscarinic receptor antagonism with significant M2 selective profile. The current examinations aimed to determine the functional significance of receptors in state hE inhibition, elucidating and M3 interaction. In vitro examinations, methacholine evoked concentration‐dependent bladder contractile atrial frequency inhibitory responses. Although atropine abolished both, methoctramine (1 μ mol/L) only affected...

10.1111/1440-1681.12191 article EN Clinical and Experimental Pharmacology and Physiology 2013-12-17

We wanted to assess whether β-adrenoceptors mediate proliferation in the normal and malignant urothelial cell lines UROtsa T24, respectively. Urothelial cells were cultured for 24 h presence of β-adrenoceptor agonists isoprenaline (β1/2/3 ), dobutamine (β1 salbutamol (β2 BRL 37344 (β3 CGP 12177 (a partial β-agonist) or antagonists (metoprolol; β1 , propranolol; β1/2 ). Phosphorylation kinases was screened with a Human Phospho-Kinase Array Kit (R&D systems). Intracellular pathways activated...

10.1111/aap.12036 article EN Autonomic and Autacoid Pharmacology 2015-09-01

Abstract Purpose The current idea of how oral mucositis (OM) develops is primarily based on hypotheses and the early events which precede clinically established OM remain to be demonstrated. Cryotherapy (CT) continues have considerable promise in clinical settings reduce chemotherapy-induced OM. Although being effective, knowledge scarce regarding ideal temperature for prevention Thus, present study had two main objectives: (i) develop an animal model investigate OM; (ii) at what cooling...

10.1007/s00280-022-04495-3 article EN cc-by Cancer Chemotherapy and Pharmacology 2022-12-01

While acetylcholine is regarded to be the main directly contractile transmitter substance in urinary bladder, interactions with other transmitters likely occur. Presently, interplay between purinergic and cholinergic signalling was investigated unravel involvement of urothelium efferent neurons functionally important purinergically evoked release vitro. Functional characterization receptor subtypes involved this also performed. In vitro organ bath experiments electrical field stimulation...

10.1016/j.autneu.2020.102693 article EN cc-by Autonomic Neuroscience 2020-06-09

The 6-hydroxydopamine (6-OHDA) rat model is one of the most common animal models Parkinson's disease. When experimentally inducing dopaminergic neurodegeneration in nigrostriatal pathway using 6-OHDA, noradrenergic reuptake inhibitor desipramine often systemically injected order to protect against damages system brain. An increasing number studies are focusing on understanding pathophysiological changes underlying autonomic non-motor symptoms, particular urinary bladder and gastrointestinal...

10.1016/j.heliyon.2020.e05472 article EN cc-by-nc-nd Heliyon 2020-11-01
Coming Soon ...